Home/Filings/4/0000899243-21-025311
4//SEC Filing

GV 2017 GP, L.L.C. 4

Accession 0000899243-21-025311

CIK 0001840574other

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 5:20 PM ET

Size

10.9 KB

Accession

0000899243-21-025311

Insider Transaction Report

Form 4
Period: 2021-06-21
Transactions
  • Conversion

    Series A Preferred Stock

    2021-06-2158,528,4280 total(indirect: By GV 2017, L.P.)
    Common Stock (6,320,905 underlying)
  • Conversion

    Common Stock

    2021-06-21+6,320,9056,320,905 total(indirect: By GV 2017, L.P.)
Transactions
  • Conversion

    Series A Preferred Stock

    2021-06-2158,528,4280 total(indirect: By GV 2017, L.P.)
    Common Stock (6,320,905 underlying)
  • Conversion

    Common Stock

    2021-06-21+6,320,9056,320,905 total(indirect: By GV 2017, L.P.)
GV 2017, L.P.
10% Owner
Transactions
  • Conversion

    Common Stock

    2021-06-21+6,320,9056,320,905 total(indirect: By GV 2017, L.P.)
  • Conversion

    Series A Preferred Stock

    2021-06-2158,528,4280 total(indirect: By GV 2017, L.P.)
    Common Stock (6,320,905 underlying)
Footnotes (2)
  • [F1]The Series A Preferred Stock converted into shares of the Issuer's common stock, $0.001 par value, on an approximately 9.2595:1 basis automatically immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date.
  • [F2]The reported securities are held directly by GV 2017, L.P. GV 2017 GP, L.P. (the general partner of GV 2017, L.P.), GV 2017 GP, L.L.C. (the general partner of GV 2017 GP, L.P.), Alphabet Holdings LLC (the sole member of GV 2017 GP, L.L.C.), XXVI Holdings Inc. (the sole member of Alphabet Holdings LLC), and Alphabet Inc. (the controlling stockholder of XXVI Holdings Inc.) may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2017 GP, L.P., GV 2017 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.

Issuer

Verve Therapeutics, Inc.

CIK 0001840574

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001733338

Filing Metadata

Form type
4
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 5:20 PM ET
Size
10.9 KB